Accumulation of the mutations in basal core promoter of hepatitis B virus subgenotype C1 increase the risk of hepatocellular carcinoma in Southern China

International Journal of Clinical and Experimental Pathology

Volumn 6, Issue 6, 2013, Pages 1076-1085

  Li, Weihua ^a   Chen, Guangyuan ^a   Yu, Xianwen ^a   Shi, Yongying ^a   Peng, Miaoguan ^a   Wei, Jianjun ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Basal core promoter; Hepatitis B virus; Hepatocellular carcinoma; Mutation; X gene

Indexed keywords

HEPATITIS B VIRUS X PROTEIN; TRANSACTIVATOR PROTEIN;

ARTICLE; BASAL CORE PROMOTER; CASE CONTROL STUDY; CELL STRAIN HEPG2; CHI SQUARE DISTRIBUTION; CHINA; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETIC TRANSFECTION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; MUTATION; PATHOGENICITY; PHENOTYPE; PROMOTER REGION; RISK FACTOR; VIROLOGY; VIRUS REPLICATION; X GENE;

BASAL CORE PROMOTER; HEPATITIS B VIRUS; HEPATOCELLULAR CARCINOMA; MUTATION; X GENE;

CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHINA; CROSS-SECTIONAL STUDIES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HEP G2 CELLS; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LIVER NEOPLASMS; MUTATION; PHENOTYPE; PROMOTER REGIONS, GENETIC; RISK FACTORS; TRANS-ACTIVATORS; TRANSFECTION; VIRUS REPLICATION;

EID: 84883011401     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Parkin DM. International variation. Oncogene 2004; 23: 6329-6340.
2. Yu MC, Yuan JM, Govindarajan S, Ross RK. Epidemiology of hepatocellular carcinoma. Can J Gastroentero 2000; 14: 703-709.
3. Miyakawa Y, Mizokami M. Classifying hepatitis B virus genotypes. Intervirology 2003; 46: 329-338.
4. Kidd-Ljunggren K, Miyakawa Y, Kidd AH. Genetic variability in hepatitis B viruses. J Gen Virol 2002; 83: 1267-1280.
5. Chan HL, Hui AY, Wong ML, Tse AM, Hung LC, Wong VW, Sung JJ. Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma. Gut 2004; 53: 1494-1498.
6. Orito E, Mizokami M, Sakugawa H, Michitaka K, Ishikawa K, Ichida T. A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C. Japan HBV Genotype Research Group. Hepatology 2001; 33: 218-223.
7. Sugauchi F, Orito E, Ichida T, Kato H, SakugawaH, Kakumu S. Hepatitis B virus of genotype B with or without recombination with genotype C over the precore region plus the core gene. J Virol 2002; 76: 5985-5992.
8. Orito E, Sugauchi F, Tanaka Y, Ichida T, Sata M, Tanaka E, Okanoue T, Sakugawa H, Watanabe H, Miyakawa H, Nishiguchi S, Kumada H, Ueda R, Mizokami M. Differences of hepatocellular carcinoma patients with hepatitis B virus genotypes of Ba, Bj or C in Japan. Intervirology 2005; 48: 239-245.
9. Sugauchi F, Orito E, Ichida T, Kato H, Sakugawa H, Kakumu S, Ishida T, Chutaputti A, Lai CL, Gish RG, Ueda R, Miyakawa Y, Mizokami M. Epidemiologic and virologic characteristics of hepatitis B virus genotype B having the recombination with genotype C. Gastroenterology 2003; 124: 925-932.
10. Huy TT, Ushijima H, Quang VX, Win KM, Luengrojanakul P, Kikuchi K, Sata T, Abe K. Genotype C of hepatitis B virus can be classified into at least two subgroups. J Gen Virol 2004; 85: 283-292.
11. Norder H, Couroucé AM, Coursaget P, Echevarria JM, Lee SD, Mushahwar IK, Robertson BH, Locarnini S, Magnius LO. Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology 2004; 47: 289-299.
12. Tanaka Y, Orito E, Yuen MF, Mukaide M, Sugauchi F, Ito K, Ozasa A, Sakamoto T, Kurbanov F, Lai CL, Mizokami M. Two subtypes (subgenotypes) of hepatitis B virus genotype C: a novel subtyping assay based on restriction fragment length polymorphism. Hepatol Res 2005; 33: 216-224.
13. Chan HL, Tsui SK, Tse CH, Ng EY, Au TC, Yuen L, Bartholomeusz A, Leung KS, Lee KH, Locarnini S, Sung JJ. Epidemiological and virological characteristics of 2 subgroups of hepatitis B virus genotype C. J Infect Dis 2005; 191: 2022-2032.
14. Kramvis A, Kew MC. The core promoter of hepatitis B virus. J Viral Hepat 1999; 6: 415-427.
15. Baptista M, Kramvis A, Kew MC. High prevalence of 1762(T) 1764(A) mutations in the basic core promoter of hepatitis B virus isolated from black Africans with hepatocellular carcinoma compared with asymptomatic carriers. Hepatology 1999; 29: 946-953.
16. Chou YC, Yu MW, Wu CF, Yang SY, Lin CL, Liu CJ, Shih WL, Chen PJ, Liaw YF, Chen CJ. Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma. Gut 2008; 57: 91-97.
17. Kao JH, Chen PJ, Lai MY, Chen DS. Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers. Gastroenterology 2003; 124: 327-334.
18. Liu CJ, Chen BF, Chen PJ, Lai MY, Huang WL, Kao JH, Chen DS. Role of hepatitis B virus precore/ core promoter mutations and serum viral load on noncirrhotic hepatocellular carcinoma: a casecontrol study. J Infect Dis 2006; 194: 594-599.
19. Yuen MF, Tanaka Y, Shinkai N, Poon RT, But DY, Fong DY, Fung J, Wong DK, Yuen JC, Mizokami M, Lai CL. Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels. Gut 2008; 57: 98-102.
20. Ito K, Tanaka Y, Orito E, Sugiyama M, Fujiwara K, Sugauchi F. T1653 mutation in the box alpha increases the risk of hepatocellular carcinoma in patients with chronic hepatitis B virus genotype C infection. Clin Infect Dis 2006; 42: 1-7.
21. Takahashi K, Ohta Y, Kanai K, Akahane Y, Iwasa Y, Hino K. Clinical implications of mutations C-to-T1653 and T-to-C/A/G1753 of hepatitis B virus genotype C genome in chronic liver disease. Arch Virol 1999; 144: 1299-1308.
22. Tanaka Y, Mukaide M, Orito E, Yuen MF, Ito K, Kurbanov F. Specific mutations in enhancer II/ core promoter of hepatitis B virus subgenotypes C1/C2 increase the risk of hepatocellular carcinoma. J Hepatol 2006; 45: 646-653.
23. Wang ZH, Huang YH, Wen SJ, Zhou B and Hou JL. Hepatitis B virus genotypes and subgenotypes in China. Hepatology Research 2007; 37: S36-S41.
24. Wang ZH, Tanaka Y, Huang YH, Kurbanov F, Chen JJ, Zeng GB. Clinical and Virological Characteristics of Hepatitis B Virus Subgenotypes Ba, C1, and C2 in China. J Clin Microbiology 2007; 45: 1491-1496.
25. Zeng G, Wang Z, Wen S. Geographic distribution, virologic and clinical characteristics of hepatitis B virus genotypes in China. J Viral Hepat 2005; 12: 609-617.
26. Xia G, Nainan OV, Jia Z. Characterization and distribution of hepatitis B virus genotypes and subtypes in 4 provinces of China. Zhonghua Liu Xing Bing Xue Za Zhi 2001; 22: 348-351; (in Chinese).
27. Wang ZJ, Zhou YP, Cheng B. An epidemiologic study on the aetiological factors of primary liver cancer in Shunde City of Guangdong province. Zhonghua Liu Xing Bing Xue Za Zhi 1996; 17: 141-144; (in Chinese).
28. Zhang S, Li L, Lu F. Mortality of primary liver cancer in China from 1990 through 1999. Zhonghua Zhong Liu Za Zhi 1999; 21: 245- 249; (in Chinese).
29. Ho SN, Hunt HD, Horton RM, Pullen JK, Pease LR. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 1989; 77: 51-59.
30. Puro R, Schneider R. Tumor necrosis factor activates a conserved innate antiviral response to hepatitis B virus that destabilizes nucleocapsids and reduces nuclear viral DNA. J Virol 2007; 81: 7351-7362.
31. Guo X, Jin Y, Qian GS, Tu H. Sequential accumulation of the mutations in core promoter of hepatitis B virus is associated with the development of hepatocellular carcinoma in Qidong, China. J Hepatology 2008; 49: 718-725.
32. Parekh S, Zoulim F, Ahn SH, Tsai A, Li J, Kawai S, Khan N, Trépo C, Wands J, Tong S. Genome replication, virion secretion, and e antigen expression of naturally occurring hepatitis B virus core promoter mutants. J Virol 2003; 77: 6601-6612.
33. Wang ZH, Tanaka Y, Huang YH, Kurbanov F, Chen JJ, Zeng GB. Clinical and Virological Characteristics of Hepatitis B Virus Subgenotypes Ba, C1, and C2 in China. J Clin Microbiology 2007; 45: 1491-1496.
34. Jammeh S, Tavner F, Watson R, Thomas HC, Karayiannis P. Effect of basal core promoter and pre-core mutations on hepatitis B virus replication. J Gen Virol 2008; 89: 901-909.
35. Block TM, Mehta AS, Fimmel CJ, Jordan R. Molecular viral oncology of hepatocellular carcinoma. Oncogene 2003; 22: 5093-5107.
36. Brechot C. Pathogenesis of hepatitis B virusrelated hepatocellular carcinoma: old and new paradigms. Gastroenterology 2004; 127: S56- S61.
37. Tanaka Y, Kanai F, Ichimura T, Tateishi K, Asaoka Y, Guleng B. The hepatitis B virus X protein enhances AP-1 activation through interaction with Jab1. Oncogene 2006; 25: 633-642.
38. Kim CM, Koike K, Saito I, Miyamura T, Jay G. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 1991; 351: 317-320.
39. Tu H, Bonura C, Giannini C, Mouly H, Soussan P, Kew M, Paterlini-Bréchot P, Bréchot C, Kremsdorf D. Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues. Cancer Res 2001; 61: 7803-7811.